3,7,12-trihydroxycholestan-26-oic acid has been researched along with pristanic acid in 2 studies
Studies (3,7,12-trihydroxycholestan-26-oic acid) | Trials (3,7,12-trihydroxycholestan-26-oic acid) | Recent Studies (post-2010) (3,7,12-trihydroxycholestan-26-oic acid) | Studies (pristanic acid) | Trials (pristanic acid) | Recent Studies (post-2010) (pristanic acid) |
---|---|---|---|---|---|
31 | 0 | 0 | 103 | 2 | 17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandt, NJ; Christensen, E; Jakobs, C; ten Brink, HJ; Wanders, RJ | 1 |
Denis, S; Seedorf, U; van Berkel, E; Wanders, RJ; Wirtz, KW; Wouters, F | 1 |
2 other study(ies) available for 3,7,12-trihydroxycholestan-26-oic acid and pristanic acid
Article | Year |
---|---|
Heterogeneity in di/trihydroxycholestanoic acidaemia.
Topics: Cholestanols; Fatty Acids; Humans; Oxidoreductases; Phytanic Acid | 1994 |
Identification of the newly discovered 58 kDa peroxisomal thiolase SCPx as the main thiolase involved in both pristanic acid and trihydroxycholestanoic acid oxidation: implications for peroxisomal beta-oxidation disorders.
Topics: Acetyl-CoA C-Acetyltransferase; Carrier Proteins; Cholestanols; Fatty Acids; Humans; Microbodies; Oxidation-Reduction; Peroxisomal Disorders | 1998 |